Stay updated on Pembrolizumab in Recurrent HNSCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent HNSCC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.3 to v3.5.4, indicating a background update to the page's content/structure without changing the study details shown to users.
    Difference
    0.1%
    Check dated 2026-05-14T22:52:45.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The study record revision was updated to v3.5.3, representing a minor update to the ClinicalTrials.gov entry.
    Difference
    0.1%
    Check dated 2026-04-30T14:36:52.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:45:06.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Adds the disease topic 'Squamous cell carcinoma of the head and neck' and a Resources section linking to the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T00:28:20.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0, with no visible changes to study details, eligibility criteria, endpoints, or locations.
    Difference
    0.1%
    Check dated 2026-03-18T17:47:19.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-11T16:52:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent HNSCC Clinical Trial page.